HHS0016895v2 Sequencers 20115695 MiSeq i100

The Texas Health and Human Services Commission (HHSC) Procurement and Contracting Services division, on behalf of the Department of State Health Services (DSHS), is issuing a formal Invitation for Bids (IFB) to procure one MiSeq i100 Plus System (Part Number 20115695), a benchtop next-generation sequencing instrument. The system deliverables include the sequencer unit with an embedded touchscreen monitor, instrument computer, control software, hardware-accelerated Dragen Bio-IT secondary analysis pipelines, 12 months of comprehensive warranty coverage including parts and labor, one preventative maintenance visit, and vendor-provided training. The equipment features upgraded chemistry with maximum run times of approximately 15.5 hours and eliminates the need for post-run instrument washes. Key evaluation criteria include firm and fixed pricing for the entire contract life, with pricing submitted on the provided Exhibit C Pricing Sheet incorporating all labor, equipment, materials, supplies, and related expenses into the unit price; optional trade-in discounts are available for an older MiSeq instrument (Serial Number M05358). The IFB was posted to the Electronic State Business Daily (ESBD) on February 24, 2026, with a questions and clarifications deadline of March 3, 2026, responses to questions posted March 5, 2026, and a bid response deadline of March 11, 2026 at 10:30 AM Central Time. The anticipated contract start date is March 2026, with an initial contract term extending through August 31, 2026, followed by an optional one-year renewal period at HHSC's sole discretion. Both HHSC and DSHS are entitled to use any awarded contract.

This procurement does not include a specific HUB (Historically Underutilized Business) set-aside requirement; however, bidders are encouraged to submit a HUB Subcontracting Plan if subcontracting opportunities exist. There are no identified incumbent vendors or technology integration requirements specified in the solicitation. Historical spend data for similar goods totaled $114,772 for Fiscal Year 2023, provided as a guideline only and not representing guaranteed quantities or contract value. Award is contingent upon HHSC Executive Commissioner approval, and the agency reserves the right to make single or multiple awards to achieve best value. All contracts remain subject to appropriations and fund availability, with no volume, usage, or compensation guaranteed. Reworked products, previously refused products, and seconds are not acceptable, and unauthorized substitutions are prohibited without prior written HHSC approval. Bidders must submit all required documentation, including Exhibit A (HHS Solicitation Affirmations), Exhibit C Pricing Sheet, and applicable Addendum Acknowledgement Forms, with failure to submit these documents resulting in automatic bid disqualification.